Health Trials

Refractory Myasthenia Gravis

2

Review clinical trials related to Refractory Myasthenia Gravis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG)

This is an open label, single arm study, to evaluate the safety , tolerability and preliminary efficacy of HN2302 for refractory myasthenia gravis.

Participants needed: 6
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: The Affiliated Hospital of Xuzhou Medical UniversityUpdated: Mar 18, 2026Locations: 1
Eligibility criteria

Age: 18-80 years, no gender restriction; [+6]

Subjects positive for hepatitis B surface antigen (HBsAg) and/or hepatitis B cor... [+10]

Read more
Status: Not yet recruiting

Allogeneic CD19-CAR-NK Cells in Patients With Refractory Myasthenia Gravis

This study is a single-center, prospective, nonrandom, single-arm trial.

Participants needed: 15
Trial details
Phase: Early Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Guangdong ProCapZoom Biosciences Co., Ltd.Updated: Nov 21, 2025
Eligibility criteria

Aged 18-65 years old, including the boundary value, no gender restriction; [+10]

Received IVMP, IVIG, or TPE within the 2 months before the current visit; [+6]

Read more